Impact of dupilumab on medical readiness in a military population.

Autor: Hill GS; Department of Otolaryngology-Head & Neck Surgery, Walter Reed National Military Medical Center, Bethesda, Maryland, USA., Noller MW; Department of Otolaryngology-Head & Neck Surgery, Walter Reed National Military Medical Center, Bethesda, Maryland, USA., Olubajo CO; School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA., Tolisano AM; Department of Otolaryngology-Head & Neck Surgery, Walter Reed National Military Medical Center, Bethesda, Maryland, USA.; Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA., Riley CA; Department of Otolaryngology-Head & Neck Surgery, Walter Reed National Military Medical Center, Bethesda, Maryland, USA.; Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA., Fischer JL; Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; Department of Otolaryngology-Head and Neck Surgery, University of California, Los Angeles, Los Angeles, California, USA.
Jazyk: angličtina
Zdroj: International forum of allergy & rhinology [Int Forum Allergy Rhinol] 2024 May; Vol. 14 (5), pp. 999-1001. Date of Electronic Publication: 2023 Nov 13.
DOI: 10.1002/alr.23300
Abstrakt: Key Points: Military servicemembers reported high satisfaction rates of dupilumab treatment for CRSwNP. Some service members fear that dupilumab treatment may limit their career progression. Updated guidelines are needed for servicemembers to make decisions regarding dupilumab.
(© 2023 ARS‐AAOA, LLC.)
Databáze: MEDLINE
Externí odkaz: